Showing results (381-390 of 434) with videos related to
Sort By:
Pageof 44
Acta Medica Okayama|December 1, 1991
A human T cell leukemia virus type-I carrier with recurrent thrombocytopenia and various autoantibodiesI Takahashi, M Sano, H Okamoto, et al.Neuroradiology|April 11, 2002
Contrast-enhanced MR angiography (enhanced 3-D fast gradient echo) for diagnosis of cerebral aneurysmsI M Suzuki, Matsui, F Ueda, et al.Cancer|May 1, 1999
The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomasM Nakajima, H Sawada, Y Yamada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1986
[Pharmacokinetics and toxicity of intrathecal administration of recombinant interleukin 2]S Miyatake, J Yamashita, Y Tokuriki, et al.Japanese Journal of Medicine|January 1, 1991
Pachydermoperiostosis with myelofibrosis and anemia: report of a case of anemia of multifactorial causes and its improvement with steroid pulse and iron therapyH Tanaka, S Maehama, F Imanaka, et al.Journal of Medicinal Chemistry|June 11, 1993
Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agentsT Terada, K Fujimoto, M Nomura, et al.Acta Medica Okayama|October 1, 1990
A variant Philadelphia chromosome (Ph1) positive chronic myelocytic leukemiaY Haruta, I Takahashi, N Sekito, et al.Cancer|April 7, 1998
Prognostic value of cyclin E and p53 expression in gastric carcinomaT Sakaguchi, A Watanabe, H Sawada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 10, 1999
[Study on CAF + medroxyprogesterone acetate (MPA) therapy for advanced or recurrent breast cancer--comparison between MPA 600 mg and 1,200 mg. Kyushu CAFT Therapy Study Group (Third Study)]S Mitsuyama, S Ohno, T Koga, et al.Histology and Histopathology|January 30, 2002
Expression of E-cadherin-catenin complex in human benign schwannomasM Hasegawa, N Muramatsu, Y Tohma, et al.Pageof 44